MTEM Molecular Templates, Inc.: Multiplikator nilai perusahaan marang pendapatan

Molecular Templates, Inc. (MTEM) - logo korporat

Molecular Templates is currently exploring strategic options or liquidating obligations through the sale of patents. This chart from the GURU.Markets platform illustrates the enterprise value assessment via EV/Sales, where the current parameter is . Molecular Templates develops "smart" toxins designed to destroy cancer cell ribosomes, while its executive scientific team focuses on the clinical validation of its unique targeted developments.

Molecular Templates - Rasio nilai perusahaan marang pendapatan MTEM (periode 04.07.2022 - 20.11.2026)

MTEM (Molecular Templates Corporation): rincian analitis lan laporan miturut indikator

- kuotasi lan prakiraan analis:
Analisis wiwitan perusahaan:MTEM, mtem.com
Produk asli Molecular Templates Corp

Fundamental asset selection requires comparing market capitalization with the actual scale of operations to identify investment imbalances. This indicator correlates the total value of the business, including debt, with annual turnover, which for Molecular Templates (MTEM), given its high cash burn and risks of clinical failures, allows for the assessment of the speculative premium over revenue via the enterprise value-to-revenue multiple.